Minimum Investment
Minimum Investment (Retail) | Lots (min) | Shares (QTY) |
₹1,27,200 | 1 | 800 |
About Chandan Healthcare Limited IPO
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand.
As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes
- 481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and
- 545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans.
The radiology facilities have eleven CT scanners and four MRI machines.
As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals.
read more >
Products and services:
The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.
- Routine Pathology Tests
- Specialized Pathology Tests
- Radiology Tests
- Preventive and Wellness Services
- Home Collection Service
Competitive Strength:
- Strong geographic presence in Uttarakhand, including 39 tier-two cities and towns.
- Integrated diagnostics provider offering pathology, radiology testing, and medical consultations.
- Track record of profitability and consistent financial performance.
- Dedicated management team with significant industry experience.
Chandan Healthcare Limited IPO Details
IPO Date | February 10, 2025 to February 12, 2025 |
Face Value | ₹10 per share |
Price Band | ₹151 to ₹159 per share |
Lot Size | 800 Shares |
Total Issue Size | 67,52,000 shares (aggregating up to ₹107.36 Cr) |
Fresh Issue | 44,52,064 shares (aggregating up to ₹ 70.79 Cr) |
Offer for Sale | 22,99,936 shares of ₹10 (aggregating up to ₹36.57 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 2,00,00,000 shares |
Share Holding Post Issue | 2,44,52,064 shares |
IPO Open Date | Monday, February 10, 2025 |
IPO Close Date | Wednesday, February 12, 2025 |
Basis of Allotment | Thursday, February 13, 2025 |
Initiation of Refunds | Friday, February 14, 2025 |
Credit of Shares to Demat | Friday, February 14, 2025 |
Listing Date | Monday, February 17, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 12, 2025 |
Chandan Healthcare Limited IPO Prospectus
Chandan Healthcare Limited Financial Snapshot (in Crore)
Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 170.06 | 128.86 | 97.83 | 81.23 |
Revenue | 167.99 | 177.96 | 137.03 | 119.92 |
Profit After Tax | 17.42 | 16.36 | 3.59 | -1.09 |
Net Worth | 41.09 | 27.3 | 23.93 | |
Reserves and Surplus | 34.31 | 21.16 | 7.37 | 4 |
Total Borrowing | 51.92 | 42.01 | 21.36 | 16.58 |
Chandan Healthcare Limited Promoters Holding
Amaranita Holdings (India) Private Limited, Amar Singh, Asmita Singh, Alok Singh, Shaleen Solanki, Vijay Singh and Vinay Lamba
Chandan Healthcare Limited Contact Details
Chandan Healthcare Limited
Biotech Park, Sector G,
Jankipuram, Kursi Road,
Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/